Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Current Deferred Tax Assets (2016)

Iradimed (IRMD) has disclosed Current Deferred Tax Assets for 4 consecutive years, with -$311871.0 as the latest value for Q4 2016.

  • On a quarterly basis, Current Deferred Tax Assets fell 320.49% to -$311871.0 in Q4 2016 year-over-year; TTM through Dec 2016 was -$311871.0, a 320.49% decrease, with the full-year FY2016 number at -$311871.0, down 320.49% from a year prior.
  • Current Deferred Tax Assets was -$311871.0 for Q4 2016 at Iradimed, down from $317709.0 in the prior quarter.
  • In the past five years, Current Deferred Tax Assets ranged from a high of $338634.0 in Q1 2016 to a low of -$311871.0 in Q4 2016.
  • A 4-year average of $137450.8 and a median of $144930.5 in 2015 define the central range for Current Deferred Tax Assets.
  • Peak YoY movement for Current Deferred Tax Assets: skyrocketed 215.69% in 2015, then plummeted 320.49% in 2016.
  • Iradimed's Current Deferred Tax Assets stood at $65961.0 in 2013, then skyrocketed by 76.38% to $116339.0 in 2014, then grew by 21.58% to $141446.0 in 2015, then tumbled by 320.49% to -$311871.0 in 2016.
  • Per Business Quant, the three most recent readings for IRMD's Current Deferred Tax Assets are -$311871.0 (Q4 2016), $317709.0 (Q3 2016), and $320587.0 (Q2 2016).